China’s Sinopharm seeks general use green light for second vaccine
Zhuang Pinghui, South China Morning Post
Posted at Feb 23 05:55 PM
Just two months after its first coronavirus vaccine was approved for general use, Chinese pharmaceutical giant Sinopharm is applying for similar regulatory approval for a second, with plans for clinical trials for a third, group chairman Liu Jingzhen said.
Read more »